891PCorrelation between immuno-related adverse events (IRAEs) occurrence and clinical outcome in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: IRAENE trial, an Italian multi-institutional retrospective study. (23rd October 2018) - Vitale, M G; Pipitone, S; Scagliarini, S; Zucali, P A; Galli, L; Rossetti, S; Caserta, C; Iacovelli, R; Masini, C; Ficorella, C; Di Girolamo, S; Buti, S; et al.